Clinical technology through Translyx
Privexa Limited builds privacy-first AI software. Translyx Limited supports healthcare, diagnostics, and clinical technology adoption pathways for selected Privexa-built products in New Zealand and Oceania.
Built by Privexa
Privacy-first AI software for regulated industries.
Privexa develops protected AI gateways, clinical workflow tools, accessibility products, and enterprise AI platforms with privacy, governance, and auditability built in.
Adopted through Translyx
Clinical technology, diagnostics, and healthcare implementation.
Translyx works with clinical audiences on diagnostic innovation, digital pathology, governed clinical AI, and healthcare adoption pathways across New Zealand and Oceania.
Connected ecosystem
Software architecture and clinical adoption working together.
Privexa focuses on product development and platform architecture. Translyx focuses on clinical engagement, healthcare pathways, and diagnostic market introduction.
Clinical ecosystem
Healthcare workflows, diagnostics, and digital pathology adoption
Through Translyx, clinical audiences can explore reviewer-gated evidence workflows, governed AI adoption, diagnostic innovation, and digital pathology partnerships. This keeps Privexa focused on software products while giving healthcare teams a dedicated clinical technology pathway.
Regulatory status and intended use vary by product and jurisdiction. Clinical and diagnostic use is subject to applicable local requirements.
Explore Privexa software and Translyx clinical technology
Review Privexa's product architecture or visit Translyx for healthcare, diagnostics, and clinical adoption pathways.